Cargando…
Inhibition of Lung Carcinoma A549 Cell Growth by Knockdown of Hexokinase 2 In Situ and In Vivo
Hexokinase 2 (HK2) has been identified as an oncogene in some malignant diseases such as breast cancer and ovarian cancer. However, the role of HK2 in lung cancer remains unclear. In this study, we explored the functional role of HK2 in lung cancer cell proliferation and tumorigenesis and determine...
Autores principales: | Xi, Feng, Ye, Jianghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842526/ https://www.ncbi.nlm.nih.gov/pubmed/26802651 http://dx.doi.org/10.3727/096504015X14459480491740 |
Ejemplares similares
-
HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo
por: LI, WEI, et al.
Publicado: (2013) -
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
por: Wang, Huanan, et al.
Publicado: (2016) -
Erratum to: Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
por: Wang, Huanan, et al.
Publicado: (2016) -
Hexokinase 2 Depletion Confers Sensitization to Metformin and Inhibits Glycolysis in Lung Squamous Cell Carcinoma
por: Guo, Wenzheng, et al.
Publicado: (2020) -
Induction of p53-independent growth inhibition in lung carcinoma cell A549 by gypenosides
por: Liu, Jung-Sen, et al.
Publicado: (2015)